VXRT - Accelerate Diagnostics and Vaxart are sharply up despite lofty short interest

In-vitro diagnostics company, Accelerate Diagnostics ([[AXDX]] +33.9%), and COVID-19 vaccine developer, Vaxart ([[VXRT]] +23.9%) operate in two entirely different industries in the healthcare sector.Given today’s steep climb in their stock prices, the two small-cap stocks share two important characteristics: they have unusually-high short interest ratios.However, with ~50.3% of short interest, Accelerate overshadows Vaxart’s short interest at ~34.25%. Today, both stocks have attracted online chatter as well.“AXDX will be squeeze of the week. 50 % short with low float. Shorty has to cover or they will be crush like GME,” read a comment on Reddit linking a short squeeze for Accelerate’s sharp gain after GameStop witnessed a similar spike despite a ~151.8% of short interest.Meanwhile, citing accomplishments of COVID-19 vaccine frontrunners and 11x rise in the past 12-month period, Forbes contributor Trefis Team says ‘Vaxart remains a very high risk, high reward type bet.’However, Seeking Alpha contributor, Edmund Ingham is bullish on the stock noting the advantages

For further details see:

Accelerate Diagnostics and Vaxart are sharply up despite lofty short interest